{
  "patientId": "77889",
  "demographics": {
    "name": "Sarah Chen",
    "dob": "1968-11-20",
    "gender": "Female",
    "address": "789 Pine Street, Anytown, USA, 12345",
    "phone": "555-7788",
    "insurance": "United Healthcare - Policy #UHC-SC-12345",
    "referringPhysician": "Dr. Emily White (ENT - Otorhinolaryngology)",
    "emergencyContact": "David Chen (Husband) - 555-7789 (Relationship: Spouse)",
    "advanceDirectives": "Full Code (Verified 02/22/2025 with patient and husband. Documented in chart.)",
    "supportServices": "Nutrition Consult (Pre-Tx for proactive PEG tube placement and dietary counseling), Speech Path Consult (Pre-Tx for baseline swallow assessment and exercises), PEG Tube placed (02/20/2025). Oncology Social Worker referral made for emotional support and resource navigation. Referred to local Head & Neck Cancer support group.",
    "mobility": "Ambulates independently. No assistive devices needed. Full range of motion in neck/shoulders."
  },
  "diagnosis": {
    "primary": "Squamous Cell Carcinoma (SCCa) of the Left Tonsil",
    "location": "Left Tonsil / Oropharynx",
    "hpvStatus": "p16 Positive (via Immunohistochemistry - IHC)",
    "datePathologicDiagnosis": "02/10/2025 (Biopsy)",
    "tnmStage": "cT2 N1 M0",
    "overallStage": "Stage I (HPV-Positive Oropharynx) - AJCC 8th Edition",
    "grade": "Well-differentiated to Moderately-differentiated Squamous Cell Carcinoma (Grade 2/3)",
    "tumorSize": "2.5 cm (largest dimension on diagnostic imaging)",
    "vascularInvolvement": "No direct vascular invasion identified on pathology or pre-treatment imaging. No distant metastases detected.",
    "pathologicStage": "pT2 pN1 M0 (Clinical staging based on pre-treatment imaging)",
    "symptomsAtPresentation": "Persistent sore throat (left side), feeling of lump in throat, dysphagia (mild difficulty swallowing solids), odynophagia (painful swallowing), palpable left neck node (Level IIA), mild weight loss (approx. 5 lbs over 2 months).",
    "pathologyFindings": [
      "Invasive Squamous Cell Carcinoma.",
      "Immunohistochemistry: Strong, diffuse p16 positivity, consistent with HPV-related oropharyngeal carcinoma. Negative for perineural invasion. Negative for lymphovascular invasion.",
      "Mitotic activity: Moderate."
    ],
    "relevantHistory": "Former smoker (quit 15 yrs ago, 10 pack-year history), social EtOH (1-2 drinks/week). No significant family history of head and neck cancer. Full dental clearance obtained pre-treatment (02/18/2025).",
    "baselineStatus": "ECOG 0 (Fully active, able to carry out all normal activity without restriction). KPS 100."
  },
  "treatmentPlan": {
    "radOnc": "Dr. James Miller",
    "medOnc": "Dr. Lisa Green",
    "surgOnc": "Dr. Emily White (ENT)",
    "gynOnc": "N/A",
    "dermatologist": "N/A",
    "treatmentSite": "Oropharynx (left tonsil primary) + Bilateral Neck Nodal Regions (Levels IB, II, III, IV, V, VII)",
    "intent": "Definitive (Curative) - Aiming for complete tumor eradication and preservation of organ function where possible.",
    "modality": "External Beam Radiation Therapy (EBRT) with concurrent Chemotherapy (Cisplatin)",
    "rtRxDetails": "70 Gy / 35 fx (2 Gy/fx) to PTV_High (Primary Gross Tumor Volume + Involved Node + 5mm margin), Simultaneous Integrated Boost (SIB) with PTV_Intermediate: 63 Gy (1.8 Gy/fx) to High-Risk Nodal Regions, PTV_Low: 56 Gy (1.6 Gy/fx) to Elective Nodal Regions.",
    "targetVolumeSummary": "Gross Tumor Volume (GTV) defined from diagnostic imaging (PET/CT and MRI) and clinical exam. PTV_High encompasses GTV + Left N1 node + margin. PTV_Intermediate includes left Levels II, III, IV and bilateral Level V. PTV_Low includes bilateral Levels IB, II, III, IV and posterior cervical chain. Comprehensive coverage to minimize recurrence risk while sparing healthy tissue.",
    "techniqueSummary": "Intensity Modulated Radiation Therapy (IMRT) - 7-field technique. Optimized for dose conformality to targets and maximal sparing of critical organs (parotid glands, spinal cord, brainstem, larynx, pharyngeal constrictor muscles, oral cavity).",
    "concurrentChemo": "Cisplatin",
    "detailedConcurrentChemo": "Cisplatin 100 mg/m^2 IV every 3 weeks (Total 3 cycles planned on Day 1, 22, 43 of RT). Administered by Dr. Lisa Green's Medical Oncology team. Patient pre-hydrated and post-hydrated for renal protection.",
    "medications": [
      "Amifostine (for xerostomia prevention - daily IV infusion prior to RT; consideration discussed with patient, decided against due to side effects)",
      "Ondansetron 8mg PO prior to chemo and PRN Nausea/Vomiting (Chemo related)",
      "Prochlorperazine 10mg PO PRN Nausea/Vomiting (Chemo related)",
      "Magic Mouthwash (Lidocaine, Diphenhydramine, Maalox) PRN Mucositis (4-6x daily as needed)",
      "Pain Medication (e.g., Oxycodone 5-10mg PO every 4-6 hours PRN severe throat pain; start as needed in 3rd week)",
      "PEG tube placed pre-treatment for nutritional support (Ensure patient is using it for all nutritional and medication needs as oral intake decreases)",
      "Topical Steroid Cream (e.g., Mometasone) PRN skin reaction (dermatitis)"
    ],
    "therapistAlerts": [
      "Assess for mucositis (oral and pharyngeal pain, redness, white patches) and skin reaction (erythema, desquamation) daily. Document grade.",
      "Verify PEG tube site is clean and dry daily; report any redness, discharge, or pain.",
      "High risk for dehydration; encourage oral fluid intake as tolerated, monitor for signs of dehydration (dry mouth, dizziness, decreased urine output), and ensure adequate PEG tube hydration. Daily weight monitoring.",
      "Strict mask fit verification for precise daily setup. Report any mask discomfort or patient motion.",
      "Monitor for vocal changes or increasing difficulty with swallowing liquids/solids, which may necessitate increased PEG tube use or pain medication adjustment.",
      "Patient is on Cisplatin; observe for signs of acute infusion reaction (rare with Cisplatin) and report any new hearing changes."
    ]
  },
  "radiationOncologyData": {
    "ctSimulation": {
      "simulationDate": "02/25/2025",
      "setupInstructions": "Supine in custom thermoplastic mask extending to shoulders, arms by sides, appropriate headrest. Shoulders retracted down with shoulder pull device to optimize field-of-view and spinal cord clearance. Patient instructed to breathe shallowly to minimize internal motion. SAD setup. Room lasers aligned to external mask marks.",
      "immobilization": "Custom thermoplastic mask (Head & Neck - extended to shoulders), Shoulder retraction device, Headrest (Type A).",
      "referenceMarks": "3-point mask marks (right, left, anterior) aligned to room lasers. Isocenter placed at L0.0 (medial-lateral), L+1.0 (superior-inferior), V-3.0 (anterior-posterior) from CT sim reference point, verified by physicist. Fiducials not used for this site.",
      "setupImages": [
        { "type": "AP", "url": "https://placehold.co/250x200/EEE/31343C?text=AP+Setup+Photo_SC77889" },
        { "type": "Lateral", "url": "https://placehold.co/250x200/EEE/31343C?text=Lateral+Setup+Photo_SC77889" }
      ],
      "scanner": "Philips Big Bore CT (Large bore opening for patient comfort and reduced artifact)",
      "sliceThickness": "2.5 mm (Optimal for H&N contouring and dose calculation)",
      "contrastUsed": "Contrast-enhanced IV (100ml Omnipaque 350mgI/ml) for GTV and nodal delineation. Bolus timing optimized for arterial phase to visualize primary and nodes.",
      "ctNotes": "CT acquired for H&N IMRT planning. Fused with diagnostic PET/CT (02/15/2025) and diagnostic MRI (02/18/2025) for comprehensive target delineation. Dental eval completed prior (no acute issues). Patient tolerated well, able to hold still throughout scan. Mask fit confirmed by therapists and deemed excellent for reproducibility."
    },
    "dosimetry": {
      "planId": "SC77889_HN_IMRT",
      "planStatus": "Final - Approved by Dr. James Miller (02/29/2025)",
      "rx": "70 Gy / 35 fx (SIB)",
      "technique": "IMRT (Static gantry, step-and-shoot delivery with 7 fields)",
      "energy": "6MV (photon energy)",
      "numberOfFieldsOrArcs": 7,
      "gantryAngles": "0, 51, 102, 153, 204, 255, 306 (Angles chosen to avoid critical structures and provide optimal dose distribution)",
      "collAngles": "Variable per field (optimized by TPS to shape beams to MLC contours)",
      "couchAngles": "0",
      "isoCoords": "L0.0, L+1.0, V-3.0 (X, Y, Z from CT reference, fixed isocenter)",
      "tps": "Pinnacle 9.10 (Treatment Planning System)",
      "algorithm": "Collapsed Cone (Advanced algorithm for heterogeneity corrections)",
      "hetero": "Yes (Full heterogeneity correction applied for tissue density variations)",
      "norm": "PTV High Mean 95% (95% of PTV_High receives 70 Gy)",
      "constraints": "Spinal Cord Max < 45 Gy (achieved 40.1 Gy); Brainstem Max < 54 Gy (achieved 48.5 Gy); Bilateral Parotid Mean < 26 Gy (L: 24.3 Gy, R: 25.8 Gy); Cochlea Mean < 30 Gy (L: 12.5 Gy, R: 11.9 Gy); Larynx Mean < 45 Gy (achieved 38.7 Gy); Pharyngeal Constrictor Mean < 60 Gy (achieved 58.1 Gy); Oral Cavity Mean < 40 Gy (achieved 35.4 Gy). All constraints met and often exceeded for protection.",
      "planNotes": "Complex H&N IMRT with SIB for definitive treatment of SCCa. Patient to receive concurrent Cisplatin every 3 weeks. Plan reviewed and approved by attending physician and physicist. Daily CBCT for IGRT. Plan quality excellent with high conformity and organ sparing.",
      "igrtProtocol": {
        "frequency": "Daily",
        "type": "Cone Beam CT (CBCT) - Full head & neck scan.",
        "alignment": "Bony anatomy of C-Spine (C2-C4 for gross shift), then fine tune to bony anatomy of skull base/mandible and soft tissue (pharyngeal air space, contour correlation). Shifts approved by R.T. on first day, and by physician weekly, otherwise therapist approved within pre-set tolerance.",
        "tolerances": "Translational: +/- 2mm; Rotational: +/- 1 degree. Outside tolerance requires physician approval for shifts or re-simulation."
      },
      "qaChecks": [
        { "date": "2025-02-28", "type": "Initial Chart Check", "by": "Physics Staff (JP)", "result": "Pass - Rx, volumes, constraints, and plan notes verified." },
        { "date": "2025-02-28", "type": "Patient Specific QA (Phantom & IMRT QA)", "by": "Physics Staff (AK)", "result": "Pass (Gamma 99.2% @ 3%/2mm); Absolute dose match within 2%." },
        { "date": "2025-02-29", "type": "Dry Run Verification", "by": "Lead Therapist (MJ)", "result": "Pass - Machine parameters, field sequencing, and couch movements verified." }
      ],
      "fieldDetails": [
        { "fieldName": "Field 1 AP", "fieldSize": "14.5x20.0 cm (MLC defined)", "gantryAngle": "0", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 80, "ssd": "91.5 cm (calculated from isocenter)" },
        { "fieldName": "Field 2 RPO", "fieldSize": "15.0x20.0 cm (MLC defined)", "gantryAngle": "51", "collimatorAngle": "30", "couchAngle": "0", "energy": "6MV", "monitorUnits": 95, "ssd": "92.0 cm (calculated from isocenter)" },
        { "fieldName": "Field 3 RAO", "fieldSize": "15.0x20.0 cm (MLC defined)", "gantryAngle": "102", "collimatorAngle": "330", "couchAngle": "0", "energy": "6MV", "monitorUnits": 90, "ssd": "92.5 cm (calculated from isocenter)" },
        { "fieldName": "Field 4 PA", "fieldSize": "14.5x20.0 cm (MLC defined)", "gantryAngle": "180", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 70, "ssd": "91.0 cm (calculated from isocenter)" },
        { "fieldName": "Field 5 LPO", "fieldSize": "15.0x20.0 cm (MLC defined)", "gantryAngle": "204", "collimatorAngle": "30", "couchAngle": "0", "energy": "6MV", "monitorUnits": 90, "ssd": "92.5 cm (calculated from isocenter)" },
        { "fieldName": "Field 6 LAO", "fieldSize": "15.0x20.0 cm (MLC defined)", "gantryAngle": "255", "collimatorAngle": "330", "couchAngle": "0", "energy": "6MV", "monitorUnits": 95, "ssd": "92.0 cm (calculated from isocenter)" },
        { "fieldName": "Field 7 L Lat", "fieldSize": "14.5x20.0 cm (MLC defined)", "gantryAngle": "306", "collimatorAngle": "0", "couchAngle": "0", "energy": "6MV", "monitorUnits": 80, "ssd": "91.5 cm (calculated from isocenter)" }
      ],
      "imagingFields": [
        { "fieldName": "CBCT (Full H&N)", "gantryAngle": "Full Arc", "fieldSize": "Volume", "energy": "kV", "monitorUnits": "N/A" }
      ]
    },
    "treatmentDelivery": {
      "fractions": [
        { 
          "fractionNumber": 1, 
          "totalFractions": 35,
          "date": "2025-03-03", 
          "machine": "LINAC1", 
          "therapistInitials": "JM, KL",
          "overallMUs": 600,
          "setupVerification": "Tolerances Met",
          "immobilizationDevicesChecked": "Mask, headrest, shoulder pulls",
          "setupAdjustments": "None",
          "organTargetChecks": "CBCT reviewed, bony anatomy (C-spine, skull base) and soft tissue (airway) aligned. Tumor bed and nodal regions confirmed.",
          "imagingType": "CBCT",
          "igrtMatchQuality": "Good - No Shifts Required",
          "shiftsApplied": "None",
          "igrtApprovedBy": "J. Miller (Physician)",
          "igrtVerificationNotes": "First treatment. CBCT match excellent. Patient tolerated mask well. Reviewed pre-meds for Cisplatin. No acute RT side effects.", 
          "patientTolerance": "Good",
          "generalSideEffects": "No acute RT side effects. Patient reports pre-meds for chemo helped with nausea.",
          "siteSpecificSideEffects": "None.",
          "painAssessment": "0/10.",
          "patientConcerns": "Expressed anxiety about upcoming weeks and potential side effects.",
          "instructionsGiven": "Reinforced importance of hydration and compliance with daily treatment. Advised to report any new symptoms.",
          "billingCodes": "77386, 77387",
          "dailyNotes": "Cycle 1 Cisplatin given today prior to RT. Patient was pre-hydrated. Treatment time 18 minutes. Confirmed appointment for Med Onc follow-up. Encouraged oral intake despite anticipation of mucositis.",
          "energiesUsed": "6MV",
          "recordedFields": [
            {"fieldName": "Field 1 AP", "deliveredMu": 80, "notes": "OK"},
            {"fieldName": "Field 2 RPO", "deliveredMu": 95, "notes": "OK"},
            {"fieldName": "Field 3 RAO", "deliveredMu": 90, "notes": "OK"},
            {"fieldName": "Field 4 PA", "deliveredMu": 70, "notes": "OK"},
            {"fieldName": "Field 5 LPO", "deliveredMu": 90, "notes": "OK"},
            {"fieldName": "Field 6 LAO", "deliveredMu": 95, "notes": "OK"},
            {"fieldName": "Field 7 L Lat", "deliveredMu": 80, "notes": "OK"}
          ]
        },
        { 
          "fractionNumber": 5, 
          "totalFractions": 35,
          "date": "2025-03-07", 
          "machine": "LINAC1", 
          "therapistInitials": "JM, KL",
          "overallMUs": 600,
          "setupVerification": "Tolerances Met",
          "immobilizationDevicesChecked": "Mask, headrest, shoulder pulls",
          "setupAdjustments": "None",
          "organTargetChecks": "CBCT reviewed, bony match confirmed. Airway stable.",
          "imagingType": "CBCT",
          "igrtMatchQuality": "Good - No Shifts Required",
          "shiftsApplied": "None",
          "igrtApprovedBy": "JM (Therapist)",
          "igrtVerificationNotes": "Routine CBCT, no significant shifts. Patient cooperative.",
          "patientTolerance": "Good",
          "generalSideEffects": "Mild fatigue.",
          "siteSpecificSideEffects": "Mild dryness in mouth.",
          "painAssessment": "0/10.",
          "patientConcerns": "None.",
          "instructionsGiven": "Continue good oral hygiene. Encouraged fluids.",
          "billingCodes": "77386, 77387",
          "dailyNotes": "Patient cooperative and comfortable. Quick setup and treatment. No visible skin reaction yet.",
          "energiesUsed": "6MV",
          "recordedFields": [
            {"fieldName": "Field 1 AP", "deliveredMu": 80, "notes": "OK"},
            {"fieldName": "Field 2 RPO", "deliveredMu": 95, "notes": "OK"},
            {"fieldName": "Field 3 RAO", "deliveredMu": 90, "notes": "OK"},
            {"fieldName": "Field 4 PA", "deliveredMu": 70, "notes": "OK"},
            {"fieldName": "Field 5 LPO", "deliveredMu": 90, "notes": "OK"},
            {"fieldName": "Field 6 LAO", "deliveredMu": 95, "notes": "OK"},
            {"fieldName": "Field 7 L Lat", "deliveredMu": 80, "notes": "OK"}
          ]
        },
        { 
          "fractionNumber": 10, 
          "totalFractions": 35,
          "date": "2025-03-14", 
          "machine": "LINAC1", 
          "therapistInitials": "KM, SN",
          "overallMUs": 600,
          "setupVerification": "Adjustments Made",
          "immobilizationDevicesChecked": "Mask, headrest, shoulder pulls",
          "setupAdjustments": "V:0.1cm, L:0cm, S:0.1cm shifts applied. Minor tilt adjustment.",
          "organTargetChecks": "CBCT reviewed, manual adjustment for patient comfort and alignment.",
          "imagingType": "CBCT",
          "igrtMatchQuality": "Good - Shifts Applied",
          "shiftsApplied": "V:0.1, L:0, S:0.1",
          "igrtApprovedBy": "J. Miller (Physician)",
          "igrtVerificationNotes": "Slight shifts due to patient settling in mask. Verified by Dr. Miller.", 
          "patientTolerance": "Good",
          "generalSideEffects": "Increasing fatigue. Mild sore throat.",
          "siteSpecificSideEffects": "Pharyngeal redness noted.",
          "painAssessment": "1/10.",
          "patientConcerns": "Reported some difficulty swallowing dry foods.",
          "instructionsGiven": "Encouraged soft diet. Use Magic Mouthwash PRN. Advised to carry water bottle.",
          "billingCodes": "77386, 77387",
          "dailyNotes": "Patient comfortable during treatment. Reminded to keep tongue still. Labs today, acceptable. OTV scheduled for next week.",
          "energiesUsed": "6MV",
          "recordedFields": [
            {"fieldName": "Field 1 AP", "deliveredMu": 80, "notes": "OK"},
            {"fieldName": "Field 2 RPO", "deliveredMu": 95, "notes": "OK"},
            {"fieldName": "Field 3 RAO", "deliveredMu": 90, "notes": "OK"},
            {"fieldName": "Field 4 PA", "deliveredMu": 70, "notes": "OK"},
            {"fieldName": "Field 5 LPO", "deliveredMu": 90, "notes": "OK"},
            {"fieldName": "Field 6 LAO", "deliveredMu": 95, "notes": "OK"},
            {"fieldName": "Field 7 L Lat", "deliveredMu": 80, "notes": "OK"}
          ]
        },
        { 
          "fractionNumber": 15, 
          "totalFractions": 35,
          "date": "2025-03-21", 
          "machine": "LINAC1", 
          "therapistInitials": "KM, SN",
          "overallMUs": 600,
          "setupVerification": "Adjustments Made",
          "immobilizationDevicesChecked": "Mask, headrest, shoulder pulls",
          "setupAdjustments": "V:0cm, L:-0.2cm, S:0.1cm shifts applied.",
          "organTargetChecks": "CBCT reviewed. Mandible alignment checked for reproducibility.",
          "imagingType": "CBCT",
          "igrtMatchQuality": "Good - Shifts Applied",
          "shiftsApplied": "V:0, L:-0.2, S:0.1",
          "igrtApprovedBy": "J. Miller (Physician)",
          "igrtVerificationNotes": "Routine CBCT, minor shifts. Patient cooperative. Dr. Miller performed OTV post-treatment.",
          "patientTolerance": "Fair",
          "generalSideEffects": "Moderate throat pain (Grade 2 mucositis). Difficulty swallowing. Increasing fatigue.",
          "siteSpecificSideEffects": "Oral cavity and oropharynx show confluent mucositis. Skin Grade 1 erythema in neck folds.",
          "painAssessment": "4/10.",
          "patientConcerns": "Expressed discomfort with swallowing; grateful for PEG tube. Asked about pain medication options.",
          "instructionsGiven": "Advised liberal use of Magic Mouthwash. Encouraged adequate hydration via PEG. Discussed starting PRN pain medication (Oxycodone).",
          "billingCodes": "77386, 77387, 77427",
          "dailyNotes": "Patient tolerating PEG feeds well. Started on Oxycodone PRN. Labs for weekly OTV drawn. Skin integrity maintained. Encouraged to try to swallow some clear liquids for taste/swallow function.",
          "energiesUsed": "6MV",
          "recordedFields": [
            {"fieldName": "Field 1 AP", "deliveredMu": 80, "notes": "OK"},
            {"fieldName": "Field 2 RPO", "deliveredMu": 95, "notes": "OK"},
            {"fieldName": "Field 3 RAO", "deliveredMu": 90, "notes": "OK"},
            {"fieldName": "Field 4 PA", "deliveredMu": 70, "notes": "OK"},
            {"fieldName": "Field 5 LPO", "deliveredMu": 90, "notes": "OK"},
            {"fieldName": "Field 6 LAO", "deliveredMu": 95, "notes": "OK"},
            {"fieldName": "Field 7 L Lat", "deliveredMu": 80, "notes": "OK"}
          ]
        },
        { 
          "fractionNumber": 22, 
          "totalFractions": 35,
          "date": "2025-03-31", 
          "machine": "LINAC1", 
          "therapistInitials": "JM, KL",
          "overallMUs": 600,
          "setupVerification": "Tolerances Met",
          "immobilizationDevicesChecked": "Mask, headrest, shoulder pulls",
          "setupAdjustments": "None",
          "organTargetChecks": "CBCT reviewed, minimal internal changes. Bony match good.",
          "imagingType": "CBCT",
          "igrtMatchQuality": "Good - No Shifts Required",
          "shiftsApplied": "None",
          "igrtApprovedBy": "SN (Therapist)",
          "igrtVerificationNotes": "Patient reports throat discomfort, but holding still well in mask. No issues with setup.", 
          "patientTolerance": "Poor",
          "generalSideEffects": "Severe throat pain (Grade 3 mucositis) requiring scheduled pain meds. Severe fatigue. Mild weight loss continues despite PEG.",
          "siteSpecificSideEffects": "Confluent mucositis with patchy exudate. Skin Grade 2 erythema/dry desquamation.",
          "painAssessment": "7/10.",
          "patientConcerns": "Concerned about pain level and fatigue. Expressed desire for treatment to end.",
          "instructionsGiven": "Reinforced scheduled pain medication use, liberal Magic Mouthwash. Encouraged small sips of water. Confirmed next Cisplatin cycle tomorrow.",
          "billingCodes": "77386, 77387",
          "dailyNotes": "Pre-meds for Cisplatin tomorrow. Patient coping with pain with medications. Maintained position well. Weekly labs drawn today.",
          "energiesUsed": "6MV",
          "recordedFields": [
            {"fieldName": "Field 1 AP", "deliveredMu": 80, "notes": "OK"},
            {"fieldName": "Field 2 RPO", "deliveredMu": 95, "notes": "OK"},
            {"fieldName": "Field 3 RAO", "deliveredMu": 90, "notes": "OK"},
            {"fieldName": "Field 4 PA", "deliveredMu": 70, "notes": "OK"},
            {"fieldName": "Field 5 LPO", "deliveredMu": 90, "notes": "OK"},
            {"fieldName": "Field 6 LAO", "deliveredMu": 95, "notes": "OK"},
            {"fieldName": "Field 7 L Lat", "deliveredMu": 80, "notes": "OK"}
          ]
        },
        { 
          "fractionNumber": 35, 
          "totalFractions": 35,
          "date": "2025-04-18", 
          "machine": "LINAC1", 
          "therapistInitials": "KM, SN",
          "overallMUs": 600,
          "setupVerification": "Tolerances Met",
          "immobilizationDevicesChecked": "Mask, headrest, shoulder pulls",
          "setupAdjustments": "None",
          "organTargetChecks": "Final CBCT reviewed, good alignment. Airway patent.",
          "imagingType": "CBCT",
          "igrtMatchQuality": "Good - No Shifts Required",
          "shiftsApplied": "None",
          "igrtApprovedBy": "J. Miller (Physician)",
          "igrtVerificationNotes": "Final treatment. Patient holding still very well despite discomfort. Mask fit maintained.", 
          "patientTolerance": "Poor",
          "generalSideEffects": "Severe fatigue. Severe mucositis, difficulty speaking. Mild dysphagia despite PEG.",
          "siteSpecificSideEffects": "Confluent mucositis with pseudomembrane (Grade 3). Skin moist desquamation (Grade 2-3) in bilateral neck folds.",
          "painAssessment": "8/10, managed with scheduled Oxycodone.",
          "patientConcerns": "Very relieved to be finishing treatment. Inquired about recovery timeline and when she can eat normally again.",
          "instructionsGiven": "Reinforced all post-treatment instructions, continued PEG use for nutrition and meds, scheduled pain meds, frequent Magic Mouthwash, gentle skin care. Provided contact information for urgent concerns. Scheduled post-RT follow-up appointments.",
          "billingCodes": "77386, 77387, 77427",
          "dailyNotes": "Completed 35/35 fractions of definitive IMRT with concurrent Cisplatin. Patient very relieved. Provided completion certificate. Instructions on continued PEG tube care and nutritional support emphasized. Weekly OTV report finalized. Patient plans to rest over the weekend.",
          "energiesUsed": "6MV",
          "recordedFields": [
            {"fieldName": "Field 1 AP", "deliveredMu": 80, "notes": "OK"},
            {"fieldName": "Field 2 RPO", "deliveredMu": 95, "notes": "OK"},
            {"fieldName": "Field 3 RAO", "deliveredMu": 90, "notes": "OK"},
            {"fieldName": "Field 4 PA", "deliveredMu": 70, "notes": "OK"},
            {"fieldName": "Field 5 LPO", "deliveredMu": 90, "notes": "OK"},
            {"fieldName": "Field 6 LAO", "deliveredMu": 95, "notes": "OK"},
            {"fieldName": "Field 7 L Lat", "deliveredMu": 80, "notes": "OK"}
          ]
        }
      ]
    }
  },
  "imagingAndReports": [
    {
      "date": "02/10/2025",
      "type": "Biopsy Report",
      "summary": "Squamous Cell Carcinoma, p16 (HPV) Positive.",
      "reportDetails": {
        "accessionNumber": "S-25-1001",
        "specimenSource": "Left Tonsil Biopsy",
        "diagnosis": "SQUAMOUS CELL CARCINOMA, INVASIVE, HPV-RELATED (p16 POSITIVE).",
        "microscopicDescription": "Sections show fragments of squamous mucosa with underlying infiltration by nests and islands of atypical squamous cells with keratinization. Mitotic figures are present (up to 5 per 10 high-power fields). Tumor extends to margins of submitted biopsy specimen. Immunohistochemical stain for p16 shows strong, diffuse nuclear and cytoplasmic positivity in the tumor cells, indicating HPV-related etiology. No lymphovascular or perineural invasion identified in this biopsy.",
        "grossDescription": "Received in formalin, a 0.5 x 0.3 x 0.2 cm irregular tan-white tissue fragment labeled 'Left Tonsil Biopsy'. Entirely submitted in cassette A1.",
        "comment": "The histologic features and p16 positivity are consistent with HPV-related invasive squamous cell carcinoma of the oropharynx. This finding typically predicts a more favorable response to chemoradiation compared to HPV-negative disease.",
        "signedBy": "Dr. A. Pathologist, 02/12/2025",
        "reviewedBy": "Dr. E. White (ENT)"
      }
    },
    {
      "date": "02/15/2025",
      "type": "Diagnostic PET/CT Scan",
      "summary": "Primary hypermetabolic lesion in left tonsil (SUVmax 15.2). Hypermetabolic left Level IIA lymph node (1.8cm, SUVmax 8.5). No distant metastases.",
      "reportDetails": {
        "accessionNumber": "PETCT-25-001",
        "protocol": "FDG PET/CT, Head to Mid-thigh",
        "findings": "Hypermetabolic focus corresponding to a mildly irregular mass in the left tonsil (2.5 x 2.0 cm), SUVmax 15.2. A hypermetabolic left Level IIA lymph node, measuring 1.8 cm in short axis, SUVmax 8.5. No other hypermetabolic lymph nodes in the neck, chest, abdomen, or pelvis. No evidence of distant metastatic disease (lungs, liver, bones, etc.).",
        "impression": "Left tonsil primary SCCa with left Level IIA lymphadenopathy. No distant metastatic disease. Consistent with cT2 N1 M0 for HPV-positive oropharynx SCCa.",
        "signedBy": "Dr. R. Radiologist, 02/16/2025"
      }
    },
    {
      "date": "02/18/2025",
      "type": "Diagnostic MRI Head & Neck",
      "summary": "Left tonsillar mass (2.6cm). Left Level IIA node (1.9cm). No deep space invasion. Optimal for fusion with CT Sim.",
      "reportDetails": {
        "accessionNumber": "MRI-HN-25-001",
        "protocol": "MRI Head and Neck with and without contrast",
        "findings": "Irregular enhancing mass centered in the left tonsil, measuring 2.6 x 2.1 x 1.5 cm. Appears to arise from the tonsillar fossa. No clear invasion of mandible or skull base. Left level IIA lymph node, ovoid, with central necrosis, measuring 1.9 x 1.5 cm. Multiple small, non-pathologic lymph nodes noted bilaterally. No evidence of cranial nerve involvement. Airway patent.",
        "impression": "Left tonsil primary lesion with suspicious left Level IIA lymph node. Conforms to cT2 N1. No overt deep space invasion identified. Imaging ideal for fusion with CT simulation data for precise target delineation.",
        "signedBy": "Dr. S. Neuroradiologist, 02/19/2025"
      }
    }
  ],
  "dicomImages": [
    {
      "description": "CT Simulation (Head & Neck - 02/25/2025)",
      "seriesType": "CT",
      "imageUrls": [
        "https://raw.githubusercontent.com/cornerstonejs/cornerstone-wado-image-loader/master/examples/images/CT000000.dcm"
      ],
      "ohifViewerUrl": "https://viewer.ohif.org/viewer/latest",
      "accessionNumber": "CT-20250225-HN"
    }
  ],
  "labResults": [
    { "date": "02/20/2025", "test": "CBC - WBC", "value": "7.5", "units": "x10^9/L", "notes": "Pre-treatment Baseline" },
    { "date": "02/20/2025", "test": "CBC - Hemoglobin", "value": "13.8", "units": "g/dL", "notes": "Pre-treatment Baseline" },
    { "date": "02/20/2025", "test": "CBC - Platelets", "value": "260k", "units": "x10^9/L", "notes": "Pre-treatment Baseline" },
    { "date": "02/20/2025", "test": "Creatinine", "value": "0.8", "units": "mg/dL", "notes": "Pre-Cisplatin Baseline - Good renal function." },
    { "date": "03/03/2025", "test": "CBC - WBC", "value": "7.2", "units": "x10^9/L", "notes": "Pre-Cycle 1 Cisplatin. RT Day 1" },
    { "date": "03/03/2025", "test": "Creatinine", "value": "0.7", "units": "mg/dL", "notes": "Pre-Cycle 1 Cisplatin." },
    { "date": "03/10/2025", "test": "CBC - WBC", "value": "6.8", "units": "x10^9/L", "notes": "Weekly Check - Tolerating RT well." },
    { "date": "03/17/2025", "test": "CBC - WBC", "value": "6.1", "units": "x10^9/L", "notes": "Weekly Check - Mild decrease, expected." },
    { "date": "03/24/2025", "test": "CBC - WBC", "value": "5.5", "units": "x10^9/L", "notes": "Pre-Cycle 2 Cisplatin. Mild leukopenia." },
    { "date": "03/24/2025", "test": "Creatinine", "value": "0.9", "units": "mg/dL", "notes": "Pre-Cycle 2 Cisplatin. Stable." },
    { "date": "03/31/2025", "test": "CBC - WBC", "value": "4.5", "units": "x10^9/L", "notes": "Weekly Check - Moderate leukopenia." },
    { "date": "04/07/2025", "test": "CBC - WBC", "value": "3.8", "units": "x10^9/L", "notes": "Weekly Check - Mild neutropenia. Continuing treatment per plan." },
    { "date": "04/14/2025", "test": "CBC - WBC", "value": "4.1", "units": "x10^9/L", "notes": "Pre-Cycle 3 Cisplatin. Counts recovering slightly. Cleared." },
    { "date": "04/14/2025", "test": "Creatinine", "value": "0.8", "units": "mg/dL", "notes": "Pre-Cycle 3 Cisplatin. Stable." }
  ],
  "progressNotes": [
    { "date": "02/22/2025", "author": "Dr. James Miller (Rad Onc)", "type": "Initial Consultation", "summary": "Pt seen for L tonsil SCCa, p16+. Discussed definitive RT w/ concurrent Cisplatin. Explained goals, RT/chemo schedule, expected acute toxicities (mucositis, dysphagia, skin, fatigue, myelosuppression, xerostomia). Reviewed PEG tube necessity. Pt verbalizes understanding and wishes to proceed. PEG tube placed by ENT pre-sim. CT Sim scheduled.", "patientTolerance": "Good", "generalSideEffects": "None", "siteSpecificSideEffects": "None", "painAssessment": "1/10 (mild sore throat)", "patientConcerns": "Concerned about ability to eat during treatment and long-term dry mouth.", "instructionsGiven": "Reassured about PEG for nutrition. Discussed Amifostine (patient declined due to side effect profile, will manage with aggressive supportive care). Reviewed oral hygiene instructions." },
    { "date": "02/25/2025", "author": "Therapist Team Lead", "type": "Simulation Note", "summary": "CT Sim completed for H&N IMRT. Mask fit excellent. Shoulder pulls achieved good retraction. Patient cooperative. Images sent to dosimetry. Diagnostic imaging fusion requested. Oral hygiene review emphasized.", "patientTolerance": "Good", "generalSideEffects": "None", "siteSpecificSideEffects": "None", "painAssessment": "0/10", "patientConcerns": "None.", "instructionsGiven": "Reviewed daily treatment process and importance of stillness. Advised no lotions on mask area before treatment." },
    { "date": "03/03/2025", "author": "Radiation Therapist", "type": "Daily Treatment Note - Fx 1", "summary": "First treatment delivered. CBCT match excellent, no shifts. Patient pre-medicated for chemo. Tolerated well. Reviewed post-chemo care and side effects.", "patientTolerance": "Good", "generalSideEffects": "No acute RT side effects.", "siteSpecificSideEffects": "None.", "painAssessment": "0/10.", "patientConcerns": "None.", "instructionsGiven": "Advised on rest and fluid intake. Reviewed anti-emetic schedule with TMZ." },
    { "date": "03/10/2025", "author": "Dr. James Miller (Rad Onc)", "type": "On Treatment Visit (OTV) - Week 1", "summary": "Patient completed 5/35 fractions. Tolerating well overall. Mild fatigue (2/10). No mucositis yet. Skin intact. Labs reviewed (WBC 6.8, Hgb 13.5, Plt 250k), acceptable. Continue RT and supportive care. Discussed hydration via PEG if oral intake declines. Scheduled Speech Path for swallow exercises.", "patientTolerance": "Good", "generalSideEffects": "Mild fatigue.", "siteSpecificSideEffects": "Mild oral dryness.", "painAssessment": "0/10.", "patientConcerns": "Asked about taste changes.", "instructionsGiven": "Advised on gentle, soft foods. Encouraged frequent sips of water. Discussed potential for taste changes." },
    { "date": "03/17/2025", "author": "Dr. James Miller (Rad Onc)", "type": "On Treatment Visit (OTV) - Week 2", "summary": "Patient completed 10/35 fractions. Starting to experience mild sore throat (2/10 pain). Using Magic Mouthwash. Fatigue increasing (4/10). Labs reviewed (WBC 6.1), acceptable. Skin shows faint erythema. Continue RT. Reinforce oral care. Next Cisplatin cycle due.", "patientTolerance": "Good", "generalSideEffects": "Increasing fatigue, mild sore throat.", "siteSpecificSideEffects": "Oropharyngeal mucosa shows mild erythema (Grade 1 mucositis).", "painAssessment": "2/10.", "patientConcerns": "Concerned about throat pain worsening.", "instructionsGiven": "Emphasized regular use of Magic Mouthwash. Advised soft, bland diet. Encouraged liberal fluid intake via PEG." },
    { "date": "03/21/2025", "author": "Radiation Therapist", "type": "Daily Treatment Note - Fx 15", "summary": "Treatment delivered. CBCT showed minor shifts (L:-0.2, S:0.1), corrected. Patient reporting moderate throat pain. Provided warm saline rinse. Patient using PEG for liquids. OTV with Dr. Miller post-treatment. Skin showing early redness. No acute issues during treatment.", "patientTolerance": "Fair", "generalSideEffects": "Moderate throat pain (Grade 2 mucositis). Increasing fatigue.", "siteSpecificSideEffects": "Oropharynx with moderate confluent mucositis. Neck skin Grade 1 erythema.", "painAssessment": "4/10.", "patientConcerns": "Expressed discomfort with swallowing; grateful for PEG tube. Inquired about options for stronger pain relief.", "instructionsGiven": "Advised liberal use of Magic Mouthwash. Encouraged adequate hydration via PEG. Discussed starting PRN pain medication (Oxycodone) with Dr. Miller during OTV." },
    { "date": "03/24/2025", "author": "Dr. Lisa Green (Med Onc)", "type": "Chemotherapy Cycle 2 Note", "summary": "Patient received Cycle 2 Cisplatin. Pre-meds administered. Hydration completed. Labs reviewed, counts acceptable. Patient tolerating RT well based on therapist notes, but mucositis is worsening. Discussed pain management. Reinforce PEG usage.", "patientTolerance": "Fair", "generalSideEffects": "Increasing fatigue, moderate nausea (controlled).", "siteSpecificSideEffects": "Oral mucositis.", "painAssessment": "4/10.", "patientConcerns": "Worried about tolerating full course of treatment.", "instructionsGiven": "Reviewed pain medication schedule. Emphasized PEG use for calories and hydration." },
    { "date": "03/31/2025", "author": "Dr. James Miller (Rad Onc)", "type": "On Treatment Visit (OTV) - Week 4", "summary": "Patient completed 20/35 fractions. Experiencing severe throat pain (6/10) requiring scheduled Oxycodone. Using PEG tube for all nutrition/meds. Mucositis is confluent with some patchy exudate. Skin in neck folds shows dry desquamation. Labs reviewed (WBC 4.5), acceptable. Discussed pain titration and continued supportive care. Continue RT. PEG is vital.", "patientTolerance": "Poor", "generalSideEffects": "Severe fatigue, severe throat pain.", "siteSpecificSideEffects": "Confluent oral mucositis, Grade 2 skin reaction (erythema/dry desquamation) in neck.", "painAssessment": "6/10 (with meds).", "patientConcerns": "Concerned about pain level and fatigue. Expressed desire for treatment to end soon.", "instructionsGiven": "Reinforced scheduled pain medication use, liberal Magic Mouthwash. Emphasized fluid intake via PEG. Advised on gentle skin cleansing." },
    { "date": "04/07/2025", "author": "Dr. James Miller (Rad Onc)", "type": "On Treatment Visit (OTV) - Week 5", "summary": "Patient completed 25/35 fractions. Pain management challenges due to severe mucositis (7/10). Increased Oxycodone to q4h. Continues full PEG dependence. Fatigue severe. Labs show mild neutropenia. Skin reaction worsening. Continue RT. Reinforced need for continuous supportive care. Last Cisplatin cycle next week.", "patientTolerance": "Poor", "generalSideEffects": "Severe fatigue, severe throat pain.", "siteSpecificSideEffects": "Confluent mucositis with pseudomembrane, Grade 2-3 skin reaction (moist desquamation) in folds.", "painAssessment": "7/10 (with meds).", "patientConcerns": "Struggling significantly with pain and fatigue. Asked about possibility of treatment break (not recommended).", "instructionsGiven": "Advised to continue all supportive measures. Discussed importance of completing full course." },
    { "date": "04/14/2025", "author": "Dr. Lisa Green (Med Onc)", "type": "Chemotherapy Cycle 3 Note", "summary": "Patient received Cycle 3 Cisplatin. Labs reviewed, counts recovering slightly, acceptable for chemo. Patient is experiencing significant mucositis and pain from RT. Full PEG dependence. Discussed post-RT plan for nutritional recovery. Pt highly motivated to finish.", "patientTolerance": "Poor", "generalSideEffects": "Severe fatigue, severe pain.", "siteSpecificSideEffects": "Oral mucositis, skin reaction.", "painAssessment": "8/10.", "patientConcerns": "Main concern is pain relief and being able to eat normally again.", "instructionsGiven": "Reviewed all post-RT recovery expectations. Encouraged continued PEG use." },
    { "date": "04/18/2025", "author": "Radiation Therapist", "type": "Daily Treatment Note - Fx 35", "summary": "Final treatment delivered. CBCT match excellent. Patient was very relieved. Provided completion certificate. Reviewed skin care and PEG tube instructions again. Final weekly OTV report sent to Dr. Miller. Patient remains compliant despite severe side effects. Treatment time 18 minutes.", "patientTolerance": "Poor", "generalSideEffects": "Severe fatigue. Severe mucositis, difficulty speaking.", "siteSpecificSideEffects": "Confluent mucositis with pseudomembrane (Grade 3). Skin moist desquamation (Grade 2-3) in bilateral neck folds.", "painAssessment": "8/10, managed with scheduled Oxycodone.", "patientConcerns": "Very relieved to be finishing treatment. Inquired about recovery timeline and when she can eat normally again.", "instructionsGiven": "Reinforced all post-treatment instructions, continued PEG use for nutrition and meds, scheduled pain meds, frequent Magic Mouthwash, gentle skin care. Provided contact information for urgent concerns. Scheduled post-RT follow-up appointments." }
  ],
  "patientEducation": {
    "goalsDiscussed": "Definitive radiation therapy with concurrent Cisplatin aims for curative treatment of HPV-positive tonsil cancer. Goals include tumor eradication, prevention of recurrence in the primary site and neck, and long-term disease control. Preservation of swallowing function and quality of life are also key aims.",
    "sideEffectsReviewed": "Common: Severe mucositis (oral and pharyngeal inflammation, pain, difficulty swallowing, requiring PEG tube for nutrition), skin reaction (erythema, dry/moist desquamation), fatigue (can be profound), dysphagia (difficulty swallowing), odynophagia (painful swallowing), xerostomia (dry mouth, often long-term/permanent), dysgeusia (taste changes). Chemotherapy-related: Nausea/vomiting, myelosuppression (lowered blood counts leading to infection/anemia risk), kidney damage (rare with hydration), neuropathy (tingling/numbness - rare for this regimen but possible with Cisplatin), hearing loss (ototoxicity - monitored with audiograms). Long-term: Fibrosis (tissue hardening), lymphedema (swelling), dental issues, potential secondary cancers (very rare).",
    "safetyConsiderations": "Critical: Strict adherence to daily RT and concurrent Cisplatin schedule. Importance of daily oral hygiene to mitigate mucositis and prevent infection. Meticulous skin care (gentle cleansing, prescribed moisturizers/creams, avoid sun/harsh products). Monitoring for signs of infection (fever, chills, severe sore throat, redness/pus at PEG site) due to low blood counts â€“ report immediately. Close pain management (scheduled pain medications as needed). Daily weight monitoring to ensure adequate hydration and nutrition via PEG. Regular communication of symptoms to the care team.",
    "patientResponsibilities": "Attend all daily RT appointments. Take all prescribed oral medications (anti-emetics, pain meds, Magic Mouthwash) as instructed. Administer PEG tube feeds and hydration as prescribed. Maintain excellent oral hygiene (frequent rinses). Perform skin care as directed. Attend weekly On-Treatment Visits (OTVs) with physician and nurses, and complete all scheduled lab draws (CBC, Creatinine). Report any new or worsening symptoms, especially concerning pain, infection, or swallowing difficulty.",
    "medicationCompliance": "Crucial to take anti-emetics prior to Cisplatin. Use Magic Mouthwash frequently (every 2-4 hours) to manage mucositis. Take pain medications proactively as pain increases. Ensure continuous hydration and nutrition via PEG tube as oral intake declines. Discuss any challenges with medication adherence or side effects with the care team promptly."
  },
  "scheduling": [
    { "date": "02/10/2025", "type": "Biopsy (L Tonsil)", "location": "ENT Clinic", "status": "Completed" },
    { "date": "02/15/2025", "type": "Diagnostic PET/CT", "location": "Imaging Department", "status": "Completed" },
    { "date": "02/18/2025", "type": "Diagnostic MRI H&N", "location": "Imaging Department", "status": "Completed" },
    { "date": "02/20/2025", "type": "PEG Tube Placement", "location": "Endoscopy Suite", "status": "Completed" },
    { "date": "02/22/2025", "type": "Rad Onc Consult", "location": "Radiation Oncology Clinic - Exam Room 1", "status": "Completed" },
    { "date": "02/25/2025", "type": "CT Simulation H&N IMRT", "location": "Radiation Oncology Sim Room", "status": "Completed" },
    { "date": "03/03/2025", "type": "First Treatment (Fx 1/35) & Chemo Cycle 1", "location": "Linear Accelerator #1 / Med Onc Infusion", "status": "Completed" },
    { "date": "03/10/2025", "type": "On Treatment Visit (OTV) - Week 1", "location": "Radiation Oncology Clinic - Exam Room 2", "status": "Completed" },
    { "date": "03/17/2025", "type": "On Treatment Visit (OTV) - Week 2", "location": "Radiation Oncology Clinic - Exam Room 2", "status": "Completed" },
    { "date": "03/24/2025", "type": "Chemo Cycle 2 (Day 22 of RT)", "location": "Med Onc Infusion Center", "status": "Completed" },
    { "date": "03/24/2025", "type": "On Treatment Visit (OTV) - Week 3", "location": "Radiation Oncology Clinic - Exam Room 1", "status": "Completed" },
    { "date": "03/31/2025", "type": "On Treatment Visit (OTV) - Week 4", "location": "Radiation Oncology Clinic - Exam Room 1", "status": "Completed" },
    { "date": "04/07/2025", "type": "On Treatment Visit (OTV) - Week 5", "location": "Radiation Oncology Clinic - Exam Room 2", "status": "Completed" },
    { "date": "04/14/2025", "type": "Chemo Cycle 3 (Day 43 of RT)", "location": "Med Onc Infusion Center", "status": "Completed" },
    { "date": "04/14/2025", "type": "On Treatment Visit (OTV) - Week 6", "location": "Radiation Oncology Clinic - Exam Room 2", "status": "Completed" },
    { "date": "04/18/2025", "type": "End of Treatment (Fx 35/35)", "location": "Linear Accelerator #1", "status": "Completed" },
    { "date": "05/16/2025", "type": "Post-RT Follow-up (Rad Onc)", "location": "Radiation Oncology Clinic - Exam Room 1", "status": "Scheduled" },
    { "date": "06/18/2025", "type": "Post-Treatment PET/CT Scan (3-Month Follow-up)", "location": "Imaging Department", "status": "Scheduled" },
    { "date": "06/25/2025", "type": "Post-Treatment Follow-up (ENT)", "location": "ENT Clinic", "status": "Scheduled" }
  ],
  "cptCharges": [
    { "code": "77290", "description": "Simulation, Complex (CT for H&N IMRT planning)", "frequency": "Once per course" },
    { "code": "77334", "description": "Treatment device, Complex (Thermoplastic Mask)", "frequency": "Once per course" },
    { "code": "77301", "description": "IMRT planning", "frequency": "Once per course" },
    { "code": "77386", "description": "Intensity modulated radiation treatment delivery, complex", "frequency": "35 fractions" },
    { "code": "77387", "description": "Guidance for localization (IGRT - CBCT)", "frequency": "35 fractions" },
    { "code": "77427", "description": "Radiation treatment management, 5 treatments", "frequency": "Weekly (7x)" },
    { "code": "99213", "description": "Office visit for OTV (Established Patient, low complexity)", "frequency": "7 visits" }
  ],
  "diagnosisSearch": "Head and Neck Cancer, Oropharyngeal SCCa"
}
